CN103245753A - Mass detection method for motherwort grains - Google Patents

Mass detection method for motherwort grains Download PDF

Info

Publication number
CN103245753A
CN103245753A CN201310147385XA CN201310147385A CN103245753A CN 103245753 A CN103245753 A CN 103245753A CN 201310147385X A CN201310147385X A CN 201310147385XA CN 201310147385 A CN201310147385 A CN 201310147385A CN 103245753 A CN103245753 A CN 103245753A
Authority
CN
China
Prior art keywords
motherwort
solution
namely
ethyl acetate
medicinal material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201310147385XA
Other languages
Chinese (zh)
Inventor
朱敏
孙蓉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kunming Chinese Medicine Factory Co Ltd
Original Assignee
Kunming Chinese Medicine Factory Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kunming Chinese Medicine Factory Co Ltd filed Critical Kunming Chinese Medicine Factory Co Ltd
Priority to CN201310147385XA priority Critical patent/CN103245753A/en
Publication of CN103245753A publication Critical patent/CN103245753A/en
Pending legal-status Critical Current

Links

Abstract

The invention provides a mass detection method for motherwort grains. The mass detection method comprises the steps of identifying, and measuring the content of motherwort, namely (1) carrying out a chromatograph condition and system suitability test, (2) preparing a reference solution, (3) preparing a test solution, and (4) measuring to ensure that the motherwort content per bag is not less than 10.0mg based on stachydrine hydrochloride (C7H13NO2.HCl). With the adoption of the mass detection method for the motherwort grains provided by the invention, the mass control standard of the motherwort grains is improved, a content determination detection index and a detection method of a main drug, namely motherwort, in a preparation are established, and a thin-layer chromatography qualitative identification method for angelica sinensis and ligusticum wallichii is added, so that the high mass standard level of the compound preparation is guaranteed.

Description

The quality determining method of the female particle of a kind of benefit
Technical field
The present invention relates to drug quality control technology field, specifically is the quality determining method of the female particle of a kind of benefit.
Background technology
The female particle of benefit is a kind of medicine for the treatment of female diseases, and its prescription is: motherwort 480g, Radix Angelicae Sinensis 240g, Ligusticum wallichii 120g, banksia rose 45g.Motherwort is the dry aerial parts of labiate motherwort Leonurus japonicus Houtt., has promoting blood circulation for regulating menstruation, inducing diuresis to reduce edema, the effect of sore detoxifcation; When being classified as labiate Radix Angelicae Sinensis Angelica sinensis(Oliv.) the dry root of Diels., having enriches blood invigorates blood circulation, the effect of menstruction regulating and pain relieving; Ligusticum wallichii is the dry rhizome of samphire Ligusticum wallichii Ligusticum chuanxiong Hort., has blood-activating and qi-promoting, the effect of wind-expelling pain-stopping; The banksia rose is the dry root of feverfew banksia rose Aucklandia lappa Decne., has promoting qi circulation and relieving pain, the effect of reinforcing spleen to promote digestion.The female particle method for making of benefit: motherwort boiling secondary, 2 hours for the first time, 1 hour for the second time, collecting decoction filtered, and it is clear cream that filtrate is condensed into relative density; Three flavors such as all the other Radix Angelicae Sinensis extracted 2 hours with 50% alcohol reflux, filtered, and merged with above-mentioned clear cream behind the filtrate recycling ethanol, were condensed into the thick paste shape, got thick paste, and are an amount of with sucrose and ethanol, make particle, and drying is made 2478g; Or get thick paste, and add aspartame and lactose is an amount of, make particle, drying is made the 531g(no cane sugar type), namely.This product is the particle of yellowish-brown, and it is sweet to distinguish the flavor of, little hardship; Or light brown to brown granular, bitter, fiber crops, little sweet (no cane sugar type).Has promoting blood circulation for regulating menstruation, the effect of promoting qi circulation and relieving pain.Be used for the women's Qi stagnation blood stasis, irregular menstruation, dysmenorrhoea, postpartum abdominalgia with blood stasis etc.In the female granular mass control method of existing benefit, do not have thin layer to differentiate there is not the assay test item yet, be difficult to control the quality of beneficial female particle.
Summary of the invention
The objective of the invention is to overcome the deficiencies in the prior art, the quality determining method of the female particle of a kind of benefit is provided, to improve the quality control standard of beneficial female particle.
The pharmaceutical formulation of the female particle of benefit is: motherwort 480g, Radix Angelicae Sinensis 240g, Ligusticum wallichii 120g, banksia rose 45g.Make 2478g or 531g(no cane sugar type) particle.
The quality determining method of the female particle of benefit of the present invention is as follows:
1) differentiate: get beneficial female particle 40g or no cane sugar type 10g, grind, add ethyl acetate 150-250ml or 30-100ml, ultrasonic processing 15-60 minute, filter, filtrate evaporate to dryness, residue add ethyl acetate 1ml makes dissolving, as need testing solution; Other gets Radix Angelicae Sinensis, each 0.2g of Ligusticum wallichii control medicinal material, respectively adds ethyl acetate 5-20ml, shines medicinal material solution in pairs with legal system; Test according to thin-layered chromatography, draw need testing solution 10~15 μ l, control medicinal material solution 5~10 μ l put respectively on same silica gel g thin-layer plate, with cyclohexane (or normal hexane)-ethyl acetate by volume proportioning 3-9:1 be developping agent, launch, take out, dry, put under the ultraviolet lamp 365nm and inspect, in the test sample chromatogram, showing the fluorescence spot of same color with the corresponding position of control medicinal material chromatogram;
2) assay:
(1) chromatographic condition and system suitability test: be filling agent with the propyl amides bonded silica gel, with acetonitrile-0.2%(volumetric concentration) glacial acetic acid by volume proportioning 81:19 be the phase that flows, detect with evaporative light-scattering detector, number of theoretical plate calculates by the stachydrine hydrochloride peak should be not less than 3000;
(2) preparation of reference substance solution: it is an amount of to get the stachydrine hydrochloride reference substance, and accurate the title decides, and adds 70% ethanol or 70% methyl alcohol (being volumetric concentration, as follows) and makes the solution that every 1ml contains 0.3mg, namely;
(3) preparation of need testing solution: get this product content under the content uniformity item, porphyrize is got about 4.5g or no cane sugar type 1g, the accurate title, decide, and puts in the tool plug conical flask, accurate 70% ethanol or the 70% methyl alcohol 25-100ml of adding, close plug claims to decide weight, ultrasonic processing 0.5-2 hour, ultrasonic processing power 100-500W, frequency 20-55kHz are put coldly, claim to decide weight again, supply the weight that subtracts mistake with 70% ethanol or 70% methyl alcohol, shake up, filter, get subsequent filtrate, namely;
(4) determination method :Precision is drawn reference substance solution 5 μ l, 10 μ l respectively, and need testing solution 10 μ l inject liquid chromatograph, measures, with the calculating of external standard two-point method logarithmic equation, namely;
This product contains motherwort with stachydrine hydrochloride (C for every bag 7H 13NO 2HCl) meter must not be less than 10.0mg.
The quality determining method of the female particle of benefit of the present invention, improved the quality control standard of beneficial female particle, the assay of setting up main ingredient motherwort in the preparation detects index and detection method thereof, increase the qualitative discrimination method of thin-layer chromatography of Radix Angelicae Sinensis, Ligusticum wallichii, guaranteed this compound preparation higher quality standard level.
Embodiment
The quality determining method of the female particle of benefit is as follows:
1) differentiate: get beneficial female particle 40g or no cane sugar type 10g, grind, add ethyl acetate 180ml or 40ml, ultrasonic processing 30 minutes filters, and filtrate evaporate to dryness, residue add ethyl acetate 1ml makes dissolving, as need testing solution; Other gets Radix Angelicae Sinensis, each 0.2g of Ligusticum wallichii control medicinal material, respectively adds ethyl acetate 10ml, shines medicinal material solution in pairs with legal system; Test according to thin-layered chromatography, draw need testing solution 10~15 μ l, control medicinal material solution 5~10 μ l put respectively on same silica gel g thin-layer plate, with cyclohexane-ethyl acetate by volume proportioning 9:1 be developping agent, launch, take out, dry, put under the ultraviolet lamp 365nm and inspect, in the test sample chromatogram, showing the fluorescence spot of same color with the corresponding position of control medicinal material chromatogram;
2) assay:
(1) chromatographic condition and system suitability test: be filling agent with the propyl amides bonded silica gel, with acetonitrile-0.2% glacial acetic acid by volume proportioning 81:19 be the phase that flows, detect with evaporative light-scattering detector, number of theoretical plate calculates by the stachydrine hydrochloride peak should be not less than 3000;
(2) preparation of reference substance solution: it is an amount of to get the stachydrine hydrochloride reference substance, and accurate the title decides, and adds 70% ethanol and makes the solution that every 1ml contains 0.3mg, namely;
(3) preparation of need testing solution: get this product content under the content uniformity item, porphyrize is got about 4.5g or no cane sugar type 1g, the accurate title, decide, and puts in the tool plug conical flask, the accurate 70% ethanol 25ml that adds, close plug claims to decide weight, ultrasonic processing 1.5 hours, ultrasonic processing power 180W, frequency 35kHz are put coldly, claim to decide weight again, supply the weight that subtracts mistake with 70% ethanol, shake up, filter, get subsequent filtrate, namely;
(4) determination method :Precision is drawn reference substance solution 5 μ l, 10 μ l respectively, and need testing solution 10 μ l inject liquid chromatograph, measures, with the calculating of external standard two-point method logarithmic equation, namely;
This product contains motherwort with C for every bag 7H 13NO 2The HCl meter must not be less than 10.0mg.
Embodiment 2:
The quality determining method of the female particle of benefit is as follows:
1) differentiate: get beneficial female particle 40g or no cane sugar type 10g, grind, add ethyl acetate 250ml or 100ml, ultrasonic processing 60 minutes filters, and filtrate evaporate to dryness, residue add ethyl acetate 1ml makes dissolving, as need testing solution; Other gets Radix Angelicae Sinensis, each 0.2g of Ligusticum wallichii control medicinal material, respectively adds ethyl acetate 20ml, shines medicinal material solution in pairs with legal system; Test according to thin-layered chromatography, draw need testing solution 10~15 μ l, control medicinal material solution 5~10 μ l put respectively on same silica gel g thin-layer plate, with normal hexane-ethyl acetate by volume proportioning 3:1 be developping agent, launch, take out, dry, put under the ultraviolet lamp 365nm and inspect, in the test sample chromatogram, showing the fluorescence spot of same color with the corresponding position of control medicinal material chromatogram;
2) assay:
(1) chromatographic condition and system suitability test: be filling agent with the propyl amides bonded silica gel, with acetonitrile-0.2% glacial acetic acid by volume proportioning 81:19 be the phase that flows, detect with evaporative light-scattering detector, number of theoretical plate calculates by the stachydrine hydrochloride peak should be not less than 3000;
(2) preparation of reference substance solution: it is an amount of to get the stachydrine hydrochloride reference substance, and accurate the title decides, and adds 70% methyl alcohol and makes the solution that every 1ml contains 0.3mg, namely;
(3) preparation of need testing solution: get this product content under the content uniformity item, porphyrize is got about 4.5g or no cane sugar type 1g, the accurate title, decide, and puts in the tool plug conical flask, the accurate 70% methyl alcohol 50ml that adds, close plug claims to decide weight, ultrasonic processing 1.5 hours, ultrasonic processing power 350W, frequency 55kHz are put coldly, claim to decide weight again, supply the weight that subtracts mistake with 70% methyl alcohol, shake up, filter, get subsequent filtrate, namely;
(4) determination method :Precision is drawn reference substance solution 5 μ l, 10 μ l respectively, and need testing solution 10 μ l inject liquid chromatograph, measures, with the calculating of external standard two-point method logarithmic equation, namely;
This product contains motherwort with C for every bag 7H 13NO 2The HCl meter must not be less than 10.0mg.
The quality control standard of the beneficial female particle after the improvement is as follows:
The female granular mass standard of benefit
The female particle of benefit
Yimu?Keli
[prescription] motherwort 480g Radix Angelicae Sinensis 240g Ligusticum wallichii 120g
Banksia rose 45g
[method for making] above four flavors, motherwort boiling secondary, 2 hours for the first time, 1 hour for the second time, collecting decoction filtered, and it is clear cream that filtrate is condensed into relative density; Three flavors such as all the other Radix Angelicae Sinensis extracted 2 hours with 50% alcohol reflux, filtered, and merged with above-mentioned clear cream behind the filtrate recycling ethanol, were condensed into the thick paste shape, got thick paste, and are an amount of with sucrose and ethanol, make particle, and drying is made 2478g; Or get thick paste, and add aspartame and lactose is an amount of, make particle, drying is made the 531g(no cane sugar type), namely.
[proterties] this product is the particle of yellowish-brown, and it is sweet to distinguish the flavor of, little hardship; Or light brown to brown granular, bitter, fiber crops, little sweet (no cane sugar type).
[discriminating] gets this product 45g or 10g(no cane sugar type), grind, add ethyl acetate 180ml or 40ml, ultrasonic processing 30 minutes filters, and filtrate evaporate to dryness, residue add ethyl acetate 1ml makes dissolving, as need testing solution.Other gets Radix Angelicae Sinensis, each 0.2g of Ligusticum wallichii control medicinal material, respectively adds ethyl acetate 10ml, shines medicinal material solution in pairs with legal system.According to thin-layered chromatography (" Chinese pharmacopoeia version VI in 2010 B) test, draw need testing solution 10~15 μ l, control medicinal material solution 5~10 μ l put respectively on same silica gel g thin-layer plate, are developping agent with cyclohexane-ethyl acetate (9:1), launch, take out, dry, put under the ultraviolet lamp (365nm) and inspect, the test sample chromatogram is showing the fluorescence spot of same color with the corresponding position of control medicinal material chromatogram.
[inspection] should meet every regulation relevant under the granule item (" Chinese pharmacopoeia version appendix in 2010 I C).
[assay] photograph high performance liquid chromatography (" an appendix VI of Chinese pharmacopoeia version in 2010 D) measure.
Chromatographic condition and system suitability testBe filling agent with the propyl amides bonded silica gel; Be the phase that flows with acetonitrile-0.2% glacial acetic acid (81:19); Detect with evaporative light-scattering detector.Number of theoretical plate calculates by the stachydrine hydrochloride peak should be not less than 3000.
The preparation of reference substance solutionIt is an amount of to get the stachydrine hydrochloride reference substance, and accurate the title decides, and adds 70% ethanol and makes the solution that every 1ml contains 0.3mg, namely.
The preparation of need testing solutionGet this product content under the content uniformity item, porphyrize is got about 4.5g or 1g(no cane sugar type), the accurate title, decide, and puts in the tool plug conical flask, the accurate 70% ethanol 25ml that adds, close plug claims to decide weight, ultrasonic processing (power 180W, frequency 35kHz) 1.5 hours, put coldly, claim to decide weight again, supply the weight that subtracts mistake with 70% ethanol, shake up, filter, get subsequent filtrate, namely.
Determination methodPrecision is drawn reference substance solution 5 μ l, 10 μ l respectively, and need testing solution 10 μ l inject liquid chromatograph, measures, with the calculating of external standard two-point method logarithmic equation, namely.
This product contains motherwort with stachydrine hydrochloride (C for every bag 7H 13NO 2HCl) meter must not be less than 10.0mg.
[function with cure mainly] promoting blood circulation for regulating menstruation, promoting qi circulation and relieving pain.Be used for qi depression to blood stasis, irregular menstruation, dysmenorrhoea, postpartum abdominalgia with blood stasis.
[usage and consumption] boiling water is taken after mixing it with water, one time 1 bag, 2 times on the one.
[attention] pregnant woman and menorrhalgia person avoid clothes.
The every packed 14g(in [specification] (1) is equivalent to medicine materical crude slice 5g); (2) every packed 3g(no cane sugar type is equivalent to medicine materical crude slice 5g)
[storage] sealing.

Claims (1)

1. the quality determining method of the female particle of benefit, the pharmaceutical formulation of beneficial female particle be by motherwort 480g, Radix Angelicae Sinensis 240g, and Ligusticum wallichii 120g, banksia rose 45g forms, and makes 2478g or 531g no cane sugar type particle; It is characterized in that carrying out according to the following steps:
1) differentiate: differentiate: get beneficial female particle 45g or no cane sugar type 10g, grind, add ethyl acetate 150-250ml or 30-100ml, ultrasonic processing 15-60 minute, filter, filtrate evaporate to dryness, residue add ethyl acetate 1ml makes dissolving, as need testing solution; Other gets Radix Angelicae Sinensis, each 0.2g of Ligusticum wallichii control medicinal material, respectively adds ethyl acetate 5-20ml, shines medicinal material solution in pairs with legal system; Test according to thin-layered chromatography, draw need testing solution 10~15 μ l, control medicinal material solution 5~10 μ l put respectively on same silica gel g thin-layer plate, with cyclohexane or normal hexane-ethyl acetate by volume proportioning 3-9:1 as developping agent, launch, take out, dry, put under the ultraviolet lamp 365nm and inspect, in the test sample chromatogram, showing the fluorescence spot of same color with the corresponding position of control medicinal material chromatogram;
2) assay:
(1) chromatographic condition and system suitability test: be filling agent with the propyl amides bonded silica gel, with acetonitrile-0.2% volumetric concentration glacial acetic acid by volume proportioning 81:19 be the phase that flows, detect with evaporative light-scattering detector, number of theoretical plate calculates by the stachydrine hydrochloride peak should be not less than 3000;
(2) preparation of reference substance solution: it is an amount of to get the stachydrine hydrochloride reference substance, accurate claims surely, adds 70% ethanol or 70% methyl alcohol is made the solution that every 1ml contains 0.3mg, namely;
(3) preparation of need testing solution: get this product content under the content uniformity item, porphyrize is got about 4.5g or no cane sugar type 1g, the accurate title, decide, and puts in the tool plug conical flask, accurate 70% ethanol or the 70% methyl alcohol 25-100ml of adding, close plug claims to decide weight, ultrasonic processing 0.5-2 hour, ultrasonic processing power 100-500W, frequency 20-55kHz are put coldly, claim to decide weight again, supply the weight that subtracts mistake with 70% ethanol or 70% methyl alcohol, shake up, filter, get subsequent filtrate, namely;
(4) determination method :Precision is drawn reference substance solution 5 μ l, 10 μ l respectively, and need testing solution 10 μ l inject liquid chromatograph, measures, with the calculating of external standard two-point method logarithmic equation, namely;
This product contains motherwort with stachydrine hydrochloride (C for every bag 7H 13NO 2HCl) meter must not be less than 10.0mg.
CN201310147385XA 2013-04-25 2013-04-25 Mass detection method for motherwort grains Pending CN103245753A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310147385XA CN103245753A (en) 2013-04-25 2013-04-25 Mass detection method for motherwort grains

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310147385XA CN103245753A (en) 2013-04-25 2013-04-25 Mass detection method for motherwort grains

Publications (1)

Publication Number Publication Date
CN103245753A true CN103245753A (en) 2013-08-14

Family

ID=48925404

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310147385XA Pending CN103245753A (en) 2013-04-25 2013-04-25 Mass detection method for motherwort grains

Country Status (1)

Country Link
CN (1) CN103245753A (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105548424A (en) * 2016-01-28 2016-05-04 南京柯菲平盛辉制药有限公司 Method for determining content of main active ingredient stachydrine hydrochloride in Naomaili granules and application of main active ingredient stachydrine hydrochloride in Naomaili granules
CN105911188A (en) * 2016-04-25 2016-08-31 广西壮族自治区梧州食品药品检验所 Method for rapid extraction-liquid chromatography-mass spectrometry tandem detection of content of stachydrine hydrochloride in Fukangning tablets
CN105911187A (en) * 2016-04-25 2016-08-31 广西壮族自治区梧州食品药品检验所 Method for liquid chromatography-mass spectrometry tandem detection of content of stachydrine hydrochloride in Fukangning tablets
CN105974038A (en) * 2016-06-24 2016-09-28 广西灵峰药业有限公司 Production quality control method of sucrose-free herba leonuri granules
CN107290441A (en) * 2017-03-29 2017-10-24 广西壮族自治区梧州食品药品检验所 A kind of method that ASE HPLC methods determine stachydrine hydrochloride content in motherwort
CN107561167A (en) * 2016-07-01 2018-01-09 天津同仁堂集团股份有限公司 A kind of detection method of musk rheumatic Dieda plaster for curing traumatic injury
CN110057945A (en) * 2019-05-29 2019-07-26 南京市中西医结合医院 The quality determining method of motherwort
CN113030344A (en) * 2021-04-14 2021-06-25 山东新宝医药有限公司 Quality control method of amber mind-tranquilizing pills

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1973897A (en) * 2006-12-21 2007-06-06 贵州益佰制药股份有限公司 Quality control method for puerperal blood clot dispersing tablet
CN101433582A (en) * 2007-11-12 2009-05-20 贵州百灵企业集团制药有限公司 Quality control method of capsule for treating prostatitis
CN101474249A (en) * 2009-01-19 2009-07-08 广西汇科药物研究有限责任公司 Motherwort and quality control method of preparation thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1973897A (en) * 2006-12-21 2007-06-06 贵州益佰制药股份有限公司 Quality control method for puerperal blood clot dispersing tablet
CN101433582A (en) * 2007-11-12 2009-05-20 贵州百灵企业集团制药有限公司 Quality control method of capsule for treating prostatitis
CN101474249A (en) * 2009-01-19 2009-07-08 广西汇科药物研究有限责任公司 Motherwort and quality control method of preparation thereof

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
BAOHONG LI ET AL.: "Simultaneous determination and pharmacokinetic study of stachydrine and leonurine in rat plasma after oral administration of Herba Leonuri extract by LC–MS/MS", 《JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS》 *
刘海英 等: "白癜风胶囊1号的薄层色谱鉴别研究", 《时珍国医国药》 *
国家药典委员会: "《中华人民共和国药典-2010年版一部》", 31 January 2010 *
张韵 等: "HPLC法测定安坤益母草片中盐酸水苏碱的含量", 《广东药学院学报》 *
李存金 等: "HPLC-ELSD 测定复方益母草胶囊中盐酸水苏碱的含量", 《中国现代应用药学》 *
陈吴苏 等: "杜仲白凤丸的薄层鉴别研究", 《现代中药研究与实践》 *

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105548424A (en) * 2016-01-28 2016-05-04 南京柯菲平盛辉制药有限公司 Method for determining content of main active ingredient stachydrine hydrochloride in Naomaili granules and application of main active ingredient stachydrine hydrochloride in Naomaili granules
CN105911188A (en) * 2016-04-25 2016-08-31 广西壮族自治区梧州食品药品检验所 Method for rapid extraction-liquid chromatography-mass spectrometry tandem detection of content of stachydrine hydrochloride in Fukangning tablets
CN105911187A (en) * 2016-04-25 2016-08-31 广西壮族自治区梧州食品药品检验所 Method for liquid chromatography-mass spectrometry tandem detection of content of stachydrine hydrochloride in Fukangning tablets
CN105974038A (en) * 2016-06-24 2016-09-28 广西灵峰药业有限公司 Production quality control method of sucrose-free herba leonuri granules
CN107561167A (en) * 2016-07-01 2018-01-09 天津同仁堂集团股份有限公司 A kind of detection method of musk rheumatic Dieda plaster for curing traumatic injury
CN107290441A (en) * 2017-03-29 2017-10-24 广西壮族自治区梧州食品药品检验所 A kind of method that ASE HPLC methods determine stachydrine hydrochloride content in motherwort
CN110057945A (en) * 2019-05-29 2019-07-26 南京市中西医结合医院 The quality determining method of motherwort
CN113030344A (en) * 2021-04-14 2021-06-25 山东新宝医药有限公司 Quality control method of amber mind-tranquilizing pills

Similar Documents

Publication Publication Date Title
CN103245753A (en) Mass detection method for motherwort grains
CN104161847B (en) A kind of quality determining method of the Chinese medicine composition treating diabetic retinopathy
CN1973897B (en) Quality control method for puerperal blood clot dispersing tablet
CN102269751B (en) Detection method of Liuweinengxiao preparation
CN103197027A (en) Quality control method of astragalus-leech capsules capable of regulating collaterals
CN109342631A (en) The construction method of the HPLC finger-print of Chinese medicine composition and the quality determining method of Chinese medicine composition
CN102335402A (en) Detection method of Chinese preparation mixture for invigorating the spleen and replenishing qi
CN102048984B (en) Blood tonifying tablets and preparation method thereof
WO2019072247A1 (en) Ultra-high-performance liquid chromatography detection method for traditional chinese medicine composition
CN101204434A (en) Quality standard for thrombus dispelling pill and test method thereof
CN108459128A (en) A kind of method of quality control of danggui sini decoction composition
CN102068627A (en) Quality control method for Chinese medicine preparation Xinnaojing tabelets
CN102038908A (en) Quality control method of tambac depression-alleviating pill as traditional Chinese medical preparation
CN100401061C (en) Quality control method of kidney beneficial bone fortifying capsule
CN104950068B (en) The kidney invigorating is dispeled the wind the quality determining method of climacteric mixture
CN100585401C (en) Detection method for orally administered formulation for reducing fat and expelling toxins
CN101732527B (en) Quality detection method for liver-soothing granules
CN101716270B (en) Method for detecting quality of traditional Chinese herbal medicament compound preparation for invigorating blood and regulating menses
CN101607037B (en) Detecting method of lanzhi brain-tranquilizing capsule
CN101385808B (en) Detection method of Zhubai tranquilizing pill
CN108459129A (en) A kind of method of quality control of Tetrandra and Poria Decoction composition
CN103211907A (en) Siwu decoction formulated particles, and preparation method and detection method thereof
CN102038921A (en) Quality control method of meridian warming pill as traditional Chinese medical preparation
CN102590436B (en) Method for identifying liquorice in Huoxiang Zhengqi oral liquid
CN102233097A (en) Quality control method for Zengguang capsules

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20130814